Chronic Knee Pain: Coolief

Added 19 Jan, 2019 [ssba]

PRESENTING COMPLAINT

The patient presented with knee pain of at least 5 years duration secondary to severe osteoarthritis. She was not keen on a knee replacement because of other co-morbidities. The pain was constant and exacerbated by activity. Her walking ability was restricted to a few steps at a time.

 

 


PREVIOUS INVESTIGATIONS/ TREATMENTS

Xray of the knee confirmed severe osteoarthritis. She had seen various specialists in the past including physiotherapists, chiropractors and the orthopaedic specialist.

Unfortunately, pain relief from injection treatment with local anaesthetic and steroids lasted only a few weeks. Medications did not help her pain significantly.


TREATMENT FROM DR. KRISHNA AT PAIN SPA

The patient saw Dr. Krishna at his private clinic in Bristol, desperate for pain relief. Dr. Krishna offered her Coolief treatment (cooled radiofrequency treatment of the knee joint), following a successful test injection with local anaesthetic (diagnostic Genicular Nerve Block). The patient had an excellent response to the radiofrequency treatment and was relatively pain-free within 2 weeks of the treatment.


OUTCOME

At the follow-up appointment 3 months after the injection, the patient reported excellent progress following Coolief treatment. She was able to walk much farther and her overall function had improved significantly. She also managed to reduce her painkillers.

She will be followed up again in 6-9 months time.

For further information please contact us at clinic@painspa.co.uk.

Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 07 Feb, 2019

Stellate Ganglion Block a Potential Lifesaver in Severe PTSD

Case reports are mounting of immediate, durable, and significant relief of severe refractory symptoms of posttraumatic stress disorder (PTSD), according to an anesthesiologist who has seen the benefits firsthand. Stellate ganglion blockade (SGB) “seems to significantly improve PTSD symptoms as well as significant...
Posted 25 Jan, 2019

CGRP Antagonists: A new era for migraine treatment

Migraine is a common medical condition, affecting as many as 37 million people in the US. It is considered a systemic illness, not just a headache. Recent research has demonstrated that changes may begin to occur in the brain as long as 24 hours before migraine symptoms begin. Many patients have a severe throbbing head...